Glutamate as a new path in discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis

Table 2 Estimation of glutamate level cut-off value

	Area under the curve	P value	95% Confidence interval		Cut-off value μg/mL (mm)	Sensitivity (%)	Specificity (%)
	Area under the curve	P value	Lower bound	Upper bound	Cut-off value μg/mL (mm)	Sensitivity (%)	Specificity (%)
NMOSD in remission versus RRMS in remission	0.782	0.0009	0.594	0.911	> 10.3	86.67	60
RRMS in remission versus RRMS in relapse	0.944	< 0.0001	0.795	0.995	> 12.6	93.33	80